Hostname: page-component-7479d7b7d-pfhbr Total loading time: 0 Render date: 2024-07-12T09:16:12.989Z Has data issue: false hasContentIssue false
  • English
  • Français

Transmission of Hepatitis B and AIDS

Published online by Cambridge University Press:  02 January 2015

Richard A. Garibaldi
Richard A. Garibaldi*
Affiliation:
Division of Infectious Diseases, University of Connecticut Health Center, Farmington, Connecticut
*
Division of Infectious Diseases, University of Connecticut Health Center, Farmington, CT 06032
Get access Rights & Permissions [Opens in a new window]

Extract

Hepatitis B virus and HTLV-III are quite dissimilar in virology, organ tropism and clinical consequences. However, they are remarkably similar in epidemiology, modes of transmission, affected risk groups, and potentials for nosocomial infection. Presently, the two diseases pose much different problems for hospital epidemiologists. Over the past 10 years, the risks of nosocomial hepatitis B have dropped off sharply. In fact, hepatitis B is now theoretically a totally preventable disease. On the other hand, the epidemic of HTLV-III infection in high-risk groups continues unabated. The fear of acquiring infection has precipitated panic reactions among some groups of health care workers and the lay public.

Type
Research Article
Information
Infection Control & Hospital Epidemiology , Volume 7 , supplement S2: Proceedings of the Second ICI/Stuart Workshop , February 1986 , pp. 132 - 134
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Blumberg, BS, Alter, HJ, Visnich, S: A “new” antigen in leukemia sera. JAMA 1965; 191:101–106.Google Scholar
2.Christenson, B: Acute infections with hepatitis B virus in medical personnel during a 15-year follow-up. Am J Epidemiol 1985; 122:411–417.Google Scholar
3.Osterholm, M, Andrews, JS: Viral hepatitis in hospital personnel in Minnesota. Minn Med 1979; 683–689.Google Scholar
4.Grady, GF, Lee, VA, Prince, AM, et al: Hepatitis B immune globulin for accidental exposures among medical personnel: Final report of a multicenter controlled trial. J Infect Dis 1978; 138:625–638.Google Scholar
5.Seeff, LB, Wright, EC, Zimmerman, HJ, et al: Type B hepatitis after needlestick exposure: Prevention with hepatitis B immune globulin. Ann Intern Med 1978; 88:285–292.Google Scholar
6.Szmuness, W, Stevens, CE, Harley, EJ: Hepatitis B vaccine in medical staff of hemodialysis units. Efficacy and subtype cross-protection. N Engl J Med 1982; 307:1481–1486.Google Scholar
7.Dienstag, JL, Werner, BG, Polk, BF: Hepatitis B vaccine in health care personnel: Safety, immunogenicity, and indicators of efficacy. Ann Intern Med 1984; 101:34–40.Google Scholar
8.Klimek, JJ, Brettman, L, Neuhaus, E, et al: A multi-hospital hepatitis B vaccine program: Prevalence of antibody and acceptance of vaccination among high-risk hospital employees. Infect Control 1985; 6:32–34.Google Scholar
9.Anderson, AC, Hodges, GR: Acceptance of hepatitis B vaccine among high-risk health care workers. Am J Infect Control 1983; 11:207–211.Google Scholar
10.Stevens, CE: Letter to editor. N Engl J Med 1983; 308:1163.Google Scholar
11.Centers for Disease Control: The safety of hepatitis B virus vaccine. MMWR 1983; 32:134–136.Google Scholar
12.Centers for Disease Control: Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR 1985; 34:105–108.Google Scholar
13.Weber, D, Rutala, W, Santimaw, J, et al: Factors associated with reduced immunogenicity of hepatitis B plasma vaccine following IM buttock injection. Twenty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. Minneapolis, MN Sept 29 - October 2, 1985.Google Scholar
14.Landesman, SH, Ginzburg, HM, Weiss, SH: Special report. The AIDS epidemic. N Engl J Med 1985; 312:521–524.Google Scholar
15.Gerberding, JL, Hopewell, PC, Kaminsky, LS, et al: Transmission of hepatitis B without transmission of AIDS by accidental needlestick (letter). N Engl J Med 1985; 312:56–57.Google Scholar
16.Glaser, JB, Garden, A: Inoculation of cryptococcosis without transmission of the Acquired Immunodeficiency Syndrome (letter). N Engl J Med 1985; 313:226.Google Scholar
17.McCray, E, Centers for Disease Control, Atlanta GA and the Cooperative Needlestick Study Group: Prospective evaluation of health-care workers with parenteral or mucous-membrane exposure to blood from patients with acquired immunodeficiency syndrome (AIDS), United States, an update. Twenty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. Minneapolis, MN, September 29 - October 2, 1985.Google Scholar
18.Weiss, SH, Rechtman, WC, Saxinger, J, et al: HTLV-III seropositivity in health care workers (HCW). Twenty-Fifth Inlerscience Conference on Antimicrobial Agents and Chemotherapy. Minneapolis, MN, September 29 - October 2, 1985.Google Scholar
19.Gerberding, JL, Moss, AR, Bryant, CE, et al: Risk of acquired immune deficiency syndrome (AIDS) virus transmission to health care workers (HCW). Twenty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. Minneapolis, MN, September 29 - October 2, 1985.Google Scholar
20.Hirsch, MS, Wormser, GP, Schooley, RT, et al: Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). N Engl J Med 1985; 312:1–4.Google Scholar
21.Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985; 34:682–695.Google Scholar
22.Centers for Disease Control: Update: Public Health Service Workshop on human T-lymphotropic virus type III antibody testing—United Stales. MMWR 1985; 477–478.Google Scholar
23.Osterholm, MT, Bowman, RJ, Chopek, MW, et al: Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis? N Engl J Med 1985; 312:1188–1185.Google Scholar